Citation Impact
Citing Papers
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
1995
Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts
2006 StandoutNobel
Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
2012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
An Integrated Approach for Analysis of the DNA Damage Response in Mammalian Cells
2015 StandoutNobel
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
2000 Standout
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Mutagenic damage to mammalian cells by therapeutic alkylating agents
1996
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Mitochondrial formation of reactive oxygen species
2003 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Prevention of anthracycline-induced cardiotoxicity in children: The evidence
2007
Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management
2014
Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
2011
Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
2010
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Biodegradable polymer implants to treat brain tumors
2001
Activity of Escherichia coli DNA-glycosylases on DNA damaged by methylating and ethylating agents and influence of 3-substituted adenine derivatives
1998
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells
2001
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
2006
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
1998
COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION
2010
Minimal Methylated Substrate and Extended Substrate Range of Escherichia coli AlkB Protein, a 1-Methyladenine-DNA Dioxygenase
2003 StandoutNobel
Antiangiogenic therapy—evolving view based on clinical trial results
2012
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
1996 StandoutNobel
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
1997
Histone deacetylases and cancer: causes and therapies
2001 Standout
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
Protecting the myocardium: A role for the β2 adrenergic receptor in the heart
2004 StandoutNobel
Malignant Gliomas in Adults
2008 Standout
Quantification of O 6 -methylguanine-DNA methyltransferase mRNA in human brain tumors
1996
Genotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)
1995
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Soft Tissue Sarcoma: An Update on Systemic Treatment Options for Patients with Advanced Disease
2014
Targeting DNA repair mechanisms in cancer
2012
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection
2013
Cardiovascular effects of systemic cancer treatment
2010
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
2003
Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
2013
O6-Alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications
1994
Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen
2004
High performance liquid chromatography analysis of MESNA (2‐mercaptoethane sulfonate) in biological samples using fluorescence detection
2004
Strategies to improve radiotherapy with targeted drugs
2011
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
2010
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 Standout
Cardiotoxicity of cytotoxic drugs
2003
Chemotherapy‐induced cardiotoxicity: current practice and prospects of prophylaxis
2002
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations
2004 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Macrophage Migration Inhibitory Factor Plays a Critical Role in Mediating Protection against the Helminth ParasiteTaenia crassiceps
2003
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
Interventions for preventing neuropathy caused by cisplatin and related compounds
2014
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
2005 StandoutNobel
Mitochondrial formation of reactive oxygen species
2003 Standout
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
2006
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.
2001
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
2009
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
1987
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity
1996
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults
2004
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Developing Drugs to Decrease the Toxicity of Chemotherapy
2001
Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps—From the American Society of Clinical Oncology
2009
Effect of SBE4-β-CD, a sulfobutyl ether β-cyclodextrin, on the stability and solubility of O6-benzylguanine (NSC-637037) in aqueous solutions
1995
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane inEgr-1deficient female mice
2001
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines.
1992
Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
2002
Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma
2014
Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.
2002 StandoutNobel
Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines.
1994
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
2007
Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents.
1998
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma
2006
Defective processing of methylated single-stranded DNA by E. coli alkB mutants
2000 StandoutNobel
Reversal of DNA alkylation damage by two human dioxygenases
2002 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
1999 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
2002 Update of Recommendations for the Use of Chemotherapy and Radiotherapy Protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology
2002
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors
2000
Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma
2002
Cardiac toxicity in cancer survivors
2013
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Second-line chemotherapy for non-small cell lung cancer
2002
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cardiovascular Complications of Cancer Therapy
2004
Works of R. Brian Mitchell being referenced
Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea
1993
Syndrome of Idiopathic Hyperammonemia after High-Dose Chemotherapy: Review of Nine Cases
1988
Modulation of Mammalian O6-Alkylguanine-DNA Alkyltransferase in vivo by O6-Benzylguanine and its Effect on the Sensitivity of a Human Glioma Tumor to l-(2-chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea
1990
Carboplatin and Paclitaxel for Previously Treated Patients with Non-small-cell Lung Cancer
1998
Sequential therapy with dacarbazine and carmustine: a phase I study
1994
Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
1992
Immunoendocrine Interactions During Chronic Cysticercosis Determine Male Mouse Feminization: Role of IL-6
2001
American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants
1999
Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin.
1985
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
1991
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
2008
Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non–Small-Cell Lung Cancer
2011